Mikko Lauri Sampsa Mannerkoski
Fondateur chez Rappta Therapeutics Oy
Profil
Mikko Lauri Sampsa Mannerkoski is the founder.
He founded Aventum Partners Oy in 2003 and Aventum Oy in 2003, where he holds the title of Partner.
He also founded Rappta Therapeutics Oy in 2019, where he currently holds the title of Chief Financial Officer.
Additionally, Mr. Mannerkoski is currently working at Mandatum & Co. Oy since 1997 as the Deputy Managing Director.
Postes actifs de Mikko Lauri Sampsa Mannerkoski
| Sociétés | Poste | Début |
|---|---|---|
Mandatum & Co. Oy
 Mandatum & Co. Oy Life/Health InsuranceFinance Mandatum & Co. Oy provides investment advice for Finnish insurance company portfolios. | Corporate Officer/Principal | 14/09/2010 |
Aventum Oy
 Aventum Oy Miscellaneous Commercial ServicesCommercial Services Aventum Oy provides advisory services within mergers and acquisitions, capital market and real estate transactions, and financial advisory. It serves private and public Finland-based corporations and institutions, private equity investors, and international industrial and financial investors active in Finland. The company was founded by Olli Markus Klemola, Harry Heikki Palmroth, Juha Petri Ruohela, and Mikko Lauri Sampsa Mannerkoski on August 29, 2003 and is headquartered in Helsinki, Finland. | Fondateur | 29/08/2003 |
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Fondateur | 20/03/2019 |
Anciens postes connus de Mikko Lauri Sampsa Mannerkoski
| Sociétés | Poste | Fin |
|---|---|---|
Aventum Partners Oy
 Aventum Partners Oy Investment ManagersFinance Aventum Partners Oy provides advisory services in merger & acquisition and capital market transactions as well as in corporate restructurings. The firm also provides corporate divestures, asset purchase, equity raising, valuation & fairness opinion, and legal consulting services. The company was founded by Mikko Lauri Sampsa Mannerkoski in 2003 and is headquartered in Helsinki, Finland. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Aventum Partners Oy
Aventum Partners Oy Investment ManagersFinance Aventum Partners Oy provides advisory services in merger & acquisition and capital market transactions as well as in corporate restructurings. The firm also provides corporate divestures, asset purchase, equity raising, valuation & fairness opinion, and legal consulting services. The company was founded by Mikko Lauri Sampsa Mannerkoski in 2003 and is headquartered in Helsinki, Finland. | Finance |
Mandatum & Co. Oy
Mandatum & Co. Oy Life/Health InsuranceFinance Mandatum & Co. Oy provides investment advice for Finnish insurance company portfolios. | Finance |
Aventum Oy
Aventum Oy Miscellaneous Commercial ServicesCommercial Services Aventum Oy provides advisory services within mergers and acquisitions, capital market and real estate transactions, and financial advisory. It serves private and public Finland-based corporations and institutions, private equity investors, and international industrial and financial investors active in Finland. The company was founded by Olli Markus Klemola, Harry Heikki Palmroth, Juha Petri Ruohela, and Mikko Lauri Sampsa Mannerkoski on August 29, 2003 and is headquartered in Helsinki, Finland. | Commercial Services |
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |
